Showing results (791-800 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|January 1, 1982
HPLC determination of benzthiazide in biologic materialM C Meyer, P Hwang, A B Straughn, et al.Biopharmaceutics & Drug Disposition|January 1, 1982
Bioavailability of phenylbutazone from a new enteric-coated formulation with superior dissolution characteristicsV A John, S Goldsborough, P J Morrison, et al.Biopharmaceutics & Drug Disposition|January 1, 1982
Relative bioavailability of acetazolamide tabletsA B Straughn, R Gollamudi, M C MeyerBiopharmaceutics & Drug Disposition|January 1, 1982
Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimensS Pancorbo, C Compty, J HeisslerBiopharmaceutics & Drug Disposition|August 13, 2016
Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitusRong Shi, Jiasheng Wu, Cong Meng, et al.Biopharmaceutics & Drug Disposition|April 29, 2020
Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically-based pharmacokinetic modelingJong Bong Lee, Simon Zhou, Manting Chiang, et al.Biopharmaceutics & Drug Disposition|November 1, 1988
Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tabletsS R Cox, M A Brown, D J Squires, et al.Biopharmaceutics & Drug Disposition|June 5, 2003
Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast and Zocor) in healthy human volunteersNaji M Najib, Nasir Idkaidek, Ayman Adel, et al.Biopharmaceutics & Drug Disposition|June 5, 2003
Pharmacokinetic scaling of SJ-8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species-invariant time methodsBeom S Shin, Dong H Kim, Chang Y Cho, et al.Biopharmaceutics & Drug Disposition|June 5, 2003
Effect of length of sampling schedule and washout interval on magnitude of drug carryover from period 1 to period 2 in two-period, two-treatment bioequivalence studies and its attendant effects on determination of bioequivalenceKuldeep Dhariwal, Andre JacksonPageof 214